Prothena Corp Public (PRTA) Change in Receivables (2012 - 2024)
Prothena Corp Public (PRTA) recorded quarterly Change in Receivables of -$5.2 million in Q1 2024, down 211.31% quarter-over-quarter from $4.6 million in Q3 2023.
Prothena Corp Public (PRTA) Change in Receivables (2012 - 2024) Analysis & Trends
Prothena Corp Public's Change in Receivables history runs 12 years deep, the most recent figure standing at -$5.2 million for Q1 2024.
- In Q1 2024, Change in Receivables changed N/A year-over-year to -$5.2 million; the TTM figure through Dec 2024 stood at -$5.2 million (down 200.0% YoY), while the FY2024 annual figure was -$5.2 million, down 200.0% from the prior year.
- Change in Receivables was -$5.2 million for Q1 2024 at Prothena Corp Public, down from $4.6 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.6 million in Q3 2023 to a low of -$5.2 million in Q1 2024.
- Historically, Change in Receivables has averaged -$6181.8 across 4 years, with a median of -$7000.0 in 2020.
- Biggest YoY gain for Change in Receivables was 2020.0% in 2020; the steepest drop was 1585.71% in 2020.
- A 4-year view of Change in Receivables shows it stood at -$7000.0 in 2020, then slumped by 1028.57% to -$79000.0 in 2021, then soared by 5967.09% to $4.6 million in 2023, then slumped by 211.31% to -$5.2 million in 2024.
- The last three Change in Receivables figures came in at -$5.2 million (Q1 2024), $4.6 million (Q3 2023), and $524000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -5.16 Mn |
| Mar 31, 2024 | -5.16 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 524,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Jun 30, 2020 | -118,000.00 |
| Jun 30, 2020 | -118,000.00 |